1/12
Looks like no tags are added yet.
“95/95/95” target
95% of people living with HIV know their status
95% of diagnosed individuals receive ART
95% of treated individuals achieve sustained viral suppression
AIDS
(acquired immunodeficiency syndrome), a life-threatening
condition characterized by extreme susceptibility to opportunistic infections and cancers. untreated HIV can cause this
ART
antiretroviral therapy, goal is create an undetectable viral load, is highly effective and has transformed HIV from a frequently fatal disease into a manageable chronic condition for many patients.
The Berlin and London patients
2 patients with blood cancer who got cured from HIV with stem cell transplant
AZT
Azidothymidine, also known as zidovudine, was the first FDA-approved anti-HIV drug.
a nucleoside reverse transcriptase inhibitor (NRTI). After entering cells, it is phosphorylated by host enzymes and incorporated into viral DNA by reverse transcriptase.
acts as a chain terminator and prevents completion of viral DNA synthesis.
CCR5 and CXCR5
G‑protein‑coupled chemokine receptors on immune cells that act as essential co‑receptors for HIV entry
CD4
what HIV infects
EX: helper T cells, macrophages, and dendritic cells
Elite controllers
can naturally maintain extremely low viral loads of HIV without ART
cytotoxic CD8 T cells, control viral replication very efficiently
Some carry protective HLA alleles such as HLA-B57 or HLA-B27
HIV is still present in the body and transmission remains possible
Latency
a reversible dormant state in which HIV hides inside infected CD4+ T cells as a silent provirus, forming a long‑lasting reservoir that does not produce virus but can reactivate later.
Neutralizing antibody
an antibody that binds a virus particle and blocks it from infecting a cell
Nucleoside analog
Nucleoside/nucleotide reverse transcriptase inhibitors, main classes of anti-HIV drugs
Opportunistic infection
infections that occur more frequently and are more severe in individuals with weakened immune systems